🇺🇸 FDA
Patent

US 9150862

siRNA targeting VEGFA and methods for treatment in vivo

granted A61KA61K31/713A61P

Quick answer

US patent 9150862 (siRNA targeting VEGFA and methods for treatment in vivo) held by Arrowhead Research Corporation expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Research Corporation
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/713, A61P, A61P17/06, A61P19/02